NCT02915744 2023-04-14
ATTAIN
Nektar Therapeutics
Phase 3 Completed
Clinical Trials
3 trialsNCT00887536 2022-04-20
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
NSABP Foundation Inc
Phase 3 Completed
NCT00983684 2014-12-05
TARGIT
University College, London
Phase 3 Completed